Emergency COVID-19 vaccine approval to require 2 months of follow-up data, FDA says
October 08 2020, 08:00
The data will help to "provide adequate information to assess a vaccine’s benefit-risk profile including adverse events."
The data will help to "provide adequate information to assess a vaccine’s benefit-risk profile including adverse events."
Source:
FOX News